{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:22Z","timestamp":1787028562142,"version":"build-2736575974"},"reference-count":34,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology of Taiwan","award":["MOST 107-2314-B-182A-151"],"award-info":[{"award-number":["MOST 107-2314-B-182A-151"]}]},{"name":"Ministry of Science and Technology of Taiwan","award":["MOST 108-2314-B-182A-137"],"award-info":[{"award-number":["MOST 108-2314-B-182A-137"]}]},{"name":"Ministry of Science and Technology of Taiwan","award":["NMRPG8H0211"],"award-info":[{"award-number":["NMRPG8H0211"]}]},{"name":"Ministry of Science and Technology of Taiwan","award":["NMRPG8J0251"],"award-info":[{"award-number":["NMRPG8J0251"]}]},{"name":"Chang Gung Memorial Hospital","award":["MOST 107-2314-B-182A-151"],"award-info":[{"award-number":["MOST 107-2314-B-182A-151"]}]},{"name":"Chang Gung Memorial Hospital","award":["MOST 108-2314-B-182A-137"],"award-info":[{"award-number":["MOST 108-2314-B-182A-137"]}]},{"name":"Chang Gung Memorial Hospital","award":["NMRPG8H0211"],"award-info":[{"award-number":["NMRPG8H0211"]}]},{"name":"Chang Gung Memorial Hospital","award":["NMRPG8J0251"],"award-info":[{"award-number":["NMRPG8J0251"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Atrial fibrillation (AF) is a leading cause of stroke, heart failure, and cardiovascular morbidity, yet its pathophysiology remains incompletely understood. Among various molecular regulators, microRNAs (miRNAs) have emerged as promising biomarkers for AF detection and burden monitoring. However, the optimal sample type for miRNA analysis remains unclear, posing a challenge for biomarker standardization. This study aimed to assess whether miRNA expression profiles remain consistent across plasma and blood cells, with a focus on identifying miRNAs with a strong predictive potential for AF burden. This exploratory study recruited patients diagnosed with sick sinus syndrome who had undergone permanent pacemaker implantation. Participants were stratified into three groups based on AF status: no AF (n = 2), paroxysmal AF (PaAF; n = 2), and persistent AF (PerAF; n = 2) for white blood cell (WBC) samples, and pooled plasma samples from no AF (n = 3 pools) and PerAF (n = 3 pools). Using an miRNA microarray analysis, miR-1-3p was consistently downregulated in both WBC and plasma samples of patients with AF, showing significant decreases (fold-change in WBC: PaAF 0.22, PerAF 0.20; plasma PerAF 0.28) and highlighting its potential as a circulating biomarker for AF burden. Additional differentially expressed miRNAs, including miR-451a and miR-382-5p, exhibited sample-dependent variations, underscoring the importance of validating miRNA expression across multiple biological compartments. The study highlights the need for mechanistic investigations to determine whether miR-1-3p directly contributes to AF pathogenesis or serves as a downstream consequence of atrial remodeling. These findings reinforce the potential of miR-1-3p as a reliable circulating biomarker for AF, offering new avenues for non-invasive monitoring and risk stratification. Future research should explore the role of miR-1-3p in AF-related molecular pathways and its applicability as a therapeutic target.<\/jats:p>","DOI":"10.3390\/ijms26104936","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T06:31:27Z","timestamp":1747809087000},"page":"4936","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["miR-1-3p Downregulation as a Consistent Biomarker for Atrial Fibrillation Burden in Patients with Sick Sinus Syndrome: A Multi-Sample Analysis"],"prefix":"10.3390","volume":"26","author":[{"given":"Hui-Ting","family":"Wang","sequence":"first","affiliation":[{"name":"Emergency Department, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan"},{"name":"School of Medicine, College of Medicine, National SunYat-sen University, Kaohsiung 80424, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5256-7429","authenticated-orcid":false,"given":"Shyh-Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4423-9246","authenticated-orcid":false,"given":"Huang-Chung","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-4976","authenticated-orcid":false,"given":"Pei-Ting","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7465-0880","authenticated-orcid":false,"given":"Yung-Lung","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Medicine, National SunYat-sen University, Kaohsiung 80424, Taiwan"},{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan"},{"name":"Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: Analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/01.CIR.96.8.2612","article-title":"Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: A prospective study","volume":"96","author":"Abe","year":"1997","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"300060520921671","DOI":"10.1177\/0300060520921671","article-title":"Inflammation as a risk factor for stroke in atrial fibrillation: Data from a microarray data analysis","volume":"48","author":"Li","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Vardas, E.P., Oikonomou, E., Vardas, P.E., and Tousoulis, D. (2024). MicroRNAs as Prognostic Biomarkers for Atrial Fibrillation Recurrence After Catheter Ablation: Current Evidence and Future Directions. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010032"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Vardas, E.P., Theofilis, P., Oikonomou, E., Vardas, P.E., and Tousoulis, D. (2024). MicroRNAs in Atrial Fibrillation: Mechanisms, Vascular Implications, and Therapeutic Potential. Biomedicines, 12.","DOI":"10.3390\/biomedicines12040811"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zeng, Q., Li, W., Luo, Z., Zhou, H., Duan, Z., and Xiong, X.L. (2023). The role of miR1 and miR133a in new-onset atrial fibrillation after acute myocardial infarction. BMC Cardiovasc. Disord., 23.","DOI":"10.1186\/s12872-023-03462-x"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Sieweke, J.T., Pfeffer, T.J., Biber, S., Chatterjee, S., Weissenborn, K., Grosse, G.M., Hagemus, J., Derda, A.A., Berliner, D., and Lichtinghagen, R. (2020). miR-21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041118"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1111\/jcmm.16985","article-title":"MicroRNA-146b-5p promotes atrial fibrosis in atrial fibrillation by repressing TIMP4","volume":"25","author":"Ye","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"da Silva, A.M., de Ara\u00fajo, J.N., de Freitas, R.C., and Silbiger, V.N. (2017). Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation. BioMed Res. Int., 2017.","DOI":"10.1155\/2017\/7804763"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Glinge, C., Clauss, S., Boddum, K., Jabbari, R., Jabbari, J., Risgaard, B., Tomsits, P., Hildebrand, B., K\u00e4\u00e4b, S., and Wakili, R. (2017). Stability of Circulating Blood-Based MicroRNAs\u2014Pre-Analytic Methodological Considerations. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0167969"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2147\/CIA.S450292","article-title":"Predictive Value of Serum microRNA-29b-3p in Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation","volume":"19","author":"Zhan","year":"2024","journal-title":"Clin. Interv. Aging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1536\/ihj.20-423","article-title":"MiR-324-3p Regulates Fibroblast Proliferation via Targeting TGF-\u03b21 in Atrial Fibrillation","volume":"61","author":"Xu","year":"2020","journal-title":"Int. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Fattahi, M., Shahrabi, S., Saadatpour, F., Rezaee, D., Beyglu, Z., Delavari, S., Amrolahi, A., Ahmadi, S., Bagheri-Mohammadi, S., and Noori, E. (2023). microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance. Int. J. Biol. Macromol., 250.","DOI":"10.1016\/j.ijbiomac.2023.125863"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Balan, A.I., and Scridon, A. (2025). MicroRNAs in atrial fibrillation\u2014Have we discovered the Holy Grail or opened a Pandora\u2019s box?. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1535621"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.trsl.2012.12.004","article-title":"MicroRNA regulation of cardiac conduction and arrhythmias","volume":"161","author":"Kim","year":"2013","journal-title":"Transl. Res."},{"key":"ref_17","first-page":"717","article-title":"Plasma levels of miRNA-1-3p are associated with subclinical atrial fibrillation in patients with cryptogenic stroke","volume":"75","author":"Benito","year":"2022","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3892\/mmr.2021.12510","article-title":"lncRNA KCNQ1OT1 may function as a competitive endogenous RNA in atrial fibrillation by sponging miR-223-3p","volume":"24","author":"Dai","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chen, X., Zhang, Y., Meng, H., Chen, G., Ma, Y., Li, J., Liu, S., Liang, Z., Xie, Y., and Liu, Y. (2024). Identification of miR-1 and miR-499 in chronic atrial fibrillation by bioinformatics analysis and experimental validation. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1400643"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.hrthm.2009.08.035","article-title":"Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation","volume":"6","author":"Girmatsion","year":"2009","journal-title":"Heart Rhythm."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhang, M.W., Shen, Y.J., Shi, J., and Yu, J.G. (2020). MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.610561"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10863-022-09934-7","article-title":"miR-29b ameliorates atrial fibrosis in rats with atrial fibrillation by targeting TGF\u03b2R\u0399 and inhibiting the activation of Smad-2\/3 pathway","volume":"54","author":"Han","year":"2022","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Harada, M., Okuzaki, D., Yamauchi, A., Ishikawa, S., Nomura, Y., Nishimura, A., Motoike, Y., Koshikawa, M., Hitachi, K., and Tsuchida, K. (2023). Circulating miR-20b-5p and miR-330-3p are novel biomarkers for progression of atrial fibrillation: Intracardiac\/extracardiac plasma sample analysis by small RNA sequencing. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0283942"},{"key":"ref_24","first-page":"1015","article-title":"Role of miRNA-499-5p in patients with atrial fibrillation and heart failure","volume":"34","author":"Wang","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s12265-022-10267-4","article-title":"Circulating exosome-derived miR-122-5p is a novel biomarker for prediction of postoperative atrial fibrillation","volume":"15","author":"Bai","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lage, R., Cebro-M\u00e1rquez, M., Vilar-S\u00e1nchez, M.E., Gonz\u00e1lez-Melchor, L., Garc\u00eda-Seara, J., Mart\u00ednez-Sande, J.L., Fern\u00e1ndez-L\u00f3pez, X.A., Arag\u00f3n-Herrera, A., Mart\u00ednez-Monzon\u00eds, M.A., and Gonz\u00e1lez-Juanatey, J.R. (2023). Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation. Cells, 12.","DOI":"10.3390\/cells12040638"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.21037\/jtd-20-2066","article-title":"Identification of microRNAs enriched in exosomes in human pericardial fluid of patients with atrial fibrillation based on bioinformatic analysis","volume":"12","author":"Liu","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s11033-020-05347-0","article-title":"LncRNA MIAT\/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis","volume":"47","author":"Yao","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jjcc.2015.12.007","article-title":"Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation","volume":"68","author":"Soeki","year":"2016","journal-title":"J. Cardiol."},{"key":"ref_30","first-page":"845","article-title":"Expression profile analysis of circulating microRNAs and their effects on ion channels in Chinese atrial fibrillation patients","volume":"8","author":"Lu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e28980","DOI":"10.1097\/MD.0000000000028980","article-title":"Upregulated miR-328-3p and its high risk in atrial fibrillation: A systematic review and meta-analysis with meta-regression","volume":"101","author":"Huang","year":"2022","journal-title":"Medicine"},{"key":"ref_32","first-page":"276","article-title":"Circulating miRNA-1-3p as Biomarker of Accelerated Sarcopenia in Patients Diagnosed with Chronic Heart Failure","volume":"74","author":"Xu","year":"2022","journal-title":"Rev. Investig. Clin."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e142548","DOI":"10.1172\/JCI142548","article-title":"miR-181b targets semaphorin 3A to mediate TGF-\u03b2-induced endothelial-mesenchymal transition related to atrial fibrillation","volume":"132","author":"Lai","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Russo, R., Zito, F., and Lampiasi, N. (2021). MiRNAs Expression Profiling in Raw264.7 Macrophages after Nfatc1-Knockdown Elucidates Potential Pathways Involved in Osteoclasts Differentiation. Biology, 10.","DOI":"10.3390\/biology10111080"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4936\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:36:23Z","timestamp":1760031383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26104936"],"URL":"https:\/\/doi.org\/10.3390\/ijms26104936","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]}}}